Having joined UC Davis Health as chief strategy officer in March 2020, Mr. Amodeo is responsible for leading the office of strategy and growth in driving strategic planning, business expansion and healthcare innovation across Northern California. Under his leadership, the health system developed a five-year clinical strategic plan, ensuring aligned growth initiatives and future sustainability. He spearheaded the $100 million cell and gene therapies initiative, aimed at advancing disease cures and reducing manufacturing costs, and played a key role in launching Health Ventures, which includes a $25 million venture fund to fuel research and commercialization partnerships. His team also designed and executed the 48X ambulatory surgery facility, the largest in the U.S., expected to increase outpatient surgeries by 5,571 per year and significantly expand inpatient surgical capacity. Additionally, he led the expansion of the UC Davis Cancer Care Network, securing key partnerships with Placerville, Calif.-based Marshall Medical Center and Chico, Calif.-based Enloe Medical Center to enhance oncology services.
